|
Italy Pharmaceuticals News. Service for global professionals. Constantly updated news and information about Italy.
Latest Italy Pharmaceuticals News
- Spain - Farming for Caviar 10 Nov 2009 00:31 GMT
... oil and cartilage is used by a pharmaceuticals company in the production of food supplements and ... and its thick, grey-black skin goes to Italy where it’s used in handbag manufacture; sturgeon are ...
- Enzon Announces Agreement to Sell Specialty Pharmaceutical Business 9 Nov 2009 13:55 GMT
... Enzon Announces Agreement to Sell Specialty Pharmaceutical Business sigma-tau to acquire business for approximately ... CEO. sigma-tau is a global R&D driven, Italian-owned pharmaceutical company dedicated, among other areas, to ... sigma-tau has its headquarters in Pomezia (Rome, Italy), and subsidiaries in France, Switzerland, Belgium, the ...
- Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million 9 Nov 2009 14:35 GMT
... Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it ... CEO. sigma-tau is a global R&D driven, Italian-owned pharmaceutical company dedicated, among other areas, to ...
- www.StockMarketingInc.com: Take a Look Now At The Hottest Newsletter!! Sign Up Today!! QPRJ "Quadra's Subsidiary Signs Sales Order for $420,000 With Fanta " 9 Nov 2009 15:37 GMT
... Nov 09, 2009 (M2 PRESSWIRE via COMTEX) -- (OTCBB: ... - EnerNOC, Inc.) (NASDAQ: ENZN - Enzon Pharmaceuticals, Inc.) (NASDAQ: AVGO - Avago Technologies Ltd.) ... CEO. sigma-tau is a global R&D driven, Italian-owned pharmaceutical company dedicated, among other areas, to ...
- The glass industry in Italy and Europe: a survey 9 Nov 2009 10:17 GMT
... • packaging (containers for food and beverages, pharmaceutical glass, etc.); • building (windows, security glass, ... the trend. In 2008, total production in Italy was steady compared to 2007 (about 5,4 ... the European market. Compared to Europe, the Italian situation is rather similar. The performance of ...
- sigma-tau Group Acquires Enzon Specialty Pharma 9 Nov 2009 15:14 GMT
... Posted on November 9, 2009 @ 08:54 am Enzon Pharmaceuticals (Booth 611) will sell its specialty pharmaceutical ... officer. sigma-tau is a global R&D driven, Italian-owned pharmaceutical company dedicated, among other areas, to ...
- Research and Markets: Consumption of Anxiolytics, Soporifics, Sedatives and Antidepressants in Portugal Increased By 32% between 2002 And 2008 9 Nov 2009 10:35 GMT
... has announced the addition of the "Portugal Pharmaceuticals and Healthcare Report Q4 2009" report to ... offering. Portugal Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, ... countries in the Western Europe matrix, above Italy and below Belgium. In global terms, Portugal is ...
- UPDATE 1-Enzon to sell specialty pharma unit 9 Nov 2009 14:39 GMT
... in cash Nov 9 (Reuters) - Enzon Pharmaceuticals Inc ( ) said it agreed to ... it agreed to sell its specialty pharmaceutical business to Italy-based pharmaceutical company, sigma-tau Group, for $300 million ...
- Enzon sells specialty drug business for $300M 9 Nov 2009 16:44 GMT
... BRIDGEWATER, N.J. (AP) -- Enzon Pharmaceuticals Inc. said Monday it is selling most ... is selling most of its business to Italian drugmaker sigma-tau Group and will focus on ...
- Enzon sells specialty drug business for $300M 9 Nov 2009 17:54 GMT
... BRIDGEWATER, N.J. (AP) - Enzon Pharmaceuticals Inc. said Monday it is selling most ... is selling most of its business to Italian drugmaker sigma-tau Group and will focus on ...
- Partnering For Global Health 9 Nov 2009 15:37 GMT
... across a specific disease, much like a pharmaceutical company manages a portfolio of drugs across ... was going to academic labs, it was industry that knew how to translate ideas into ... 25 scientists at a vaccines center in Italy. GSK has 52 full-time scientists working on neglected ...
- 16-22 9 Nov 2009 15:37 GMT
... across a specific disease, much like a pharmaceutical company manages a portfolio of drugs across ... was going to academic labs, it was industry that knew how to translate ideas into ... 25 scientists at a vaccines center in Italy. GSK has 52 full-time scientists working on neglected ...
- SciClone Reports Financial Results and Provides Commercial and Pipeline Updates for the Third Quarte 9 Nov 2009 12:37 GMT
... and Year End Cash Guidance Increased SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results ... continued growth, as we build our China business and advance our proprietary pipeline of product ... pandemic flu H1N1 vaccines. Preclinical studies in Italy have demonstrated the feasibility of one or two ...
- SciClone Reports Financial Results and Provides Commercial and Pipeline Updates for the Third Quarter of 2009 9 Nov 2009 12:40 GMT
... CA--(Marketwire - November 9, 2009) - SciClone Pharmaceuticals, Inc. ( ) today reported financial results ... continued growth, as we build our China business and advance our proprietary pipeline of product ... pandemic flu H1N1 vaccines. Preclinical studies in Italy have demonstrated the feasibility of one or two ...
- Gentium Announces New Board of Directors and Interim CEO 9 Nov 2009 12:50 GMT
... partner at Reconta Ernst & Young (the Italian affiliate of Ernst & Young LLP), previous ... Chairman and Chief Executive Officer of Indevus Pharmaceuticals, has held numerous executive level positions at ... media section. Gentium S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
latimes.com:
cnn.com:
nytimes.com:
reuters.com:
bbc.co.uk:
wsj.com: